Academic Leadership Award at the Indiana University School of Medicine
Academic Leadership Award at the Indiana University School of Medicine
批准号:
10532250
负责人:
GARY E. LANDRETH
金额:
$16.19万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-01 至 2024-12-31
关键词:
AgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease related dementiaAnimal ModelAwardBasic ScienceCaliberClinicalClinical TrialsCollaborationsCommunitiesDevelopmentDoctor of MedicineEarly Onset Alzheimer DiseaseEducationEducational CurriculumEducational StatusElementsEmployeeFacultyFundingGoalsGraduate EducationHomeHuman ResourcesIndianaIndividualInstitutionInstructionInvestmentsLaboratoriesLeadershipMedicalNeurodegenerative DisordersNeurosciencesNeurosciences ResearchPostdoctoral FellowPrincipal InvestigatorResearchResearch ActivityResearch InstituteResearch PersonnelResourcesSeriesTalentsTrainingTraining ActivityTraining ProgramsTraining SupportTranslational ResearchUniversitiesWorkacademic programagedbrain healthcell repositorycognitive functiondesigndoctoral studentexperiencegraduate studentmedical schoolspost-doctoral trainingprogramsrecruitskillssuccessundergraduate research experience
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Principal Investigator: Landreth, Gary E
Project Summary/Abstract
This academic leadership award application is directed at the development of coordinated and
comprehensive educational programs in aging, Alzheimer’s disease and related dementias at the Indiana
University School of Medicine (IUSM). A primary goal is to provide an organizational framework, anchored in
the Medical Neurosciences Training Program, to functionally integrate the activities of existing and developing
NIA supported resources at the IUSM. The NIA supports the Indiana Alzheimer’s Disease Research Center,
the National Cell Repository for Alzheimer’s Disease, the Regenstrief Institute and the Center for Aging
Research as well as the recently funded MODEL-AD center and LEADS clinical trial. Finally, Eli Lilly is
headquartered in Indianapolis and has a substantial research effort focused on Alzheimer’s disease. These
institutions comprise a unique and significant intellectual and infrastructural resource that will be leveraged in
the current proposal.
The IUSM and the NIA have recently committed substantial institutional resources to develop basic
science research efforts on AD and neurodegenerative diseases. However, the success of the investigative
effort will be contingent upon provision of a skilled workforce. The present application describes a plan to
employ the Medical Neuroscience Training program as a vehicle to enhance and coordinate the research and
training activities at the IUSM. The training program will simultaneously enhance and expand the institutional
research capacity by providing a talented pool of young investigators to faculty within the individual research
centers, and provide a high level training for these individuals. Importantly, the activities of the training
program provide a mechanism to promote interactions and collaborations between the faculty and research
staff at IUSM and Lilly who work on aging and neurodegenerative diseases.
The applicant, Dr. Gary Landreth, was recruited to IUSM to lead the development and restructuring of the
Medical Neurosciences Training Program. He brings to this effort 30 years of experience in Alzheimer’s
disease research and graduate education.
The Specific Aims of the application are:1) To restructure the Medical Neuroscience Training program
through a) modernizing the graduate curriculum to provide foundational training in the Neurosciences, aging
and neurodegenerative diseases, b) initiation of a postdoctoral training program to promote the professional
advancement of this important component of the scientific workforce and c) provide undergraduate research
experiences. 2) To employ the Medical Neuroscience Training Program as a vehicle to integrate the activities
of the various IUSM centers focused on Aging and Neurodegenerative diseases. 3) To promote translational
research interactions through the Medical Neuroscience Training Program with Eli Lilly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Repurposing FDA-approved agonists of HCAR2 as novel therapeutics for Alzheimer's Disease
-
批准号:10416432
-
项目类别:
-
资助金额:$169.15万
-
财政年份:2022
-
负责人:GARY E. LANDRETH
-
依托单位:
Training Grant on Alzheimer's Disease and ADRD at Indiana University
-
批准号:10627778
-
项目类别:
-
资助金额:$51.26万
-
财政年份:2021
-
负责人:GARY E. LANDRETH
-
依托单位:
Training Grant on Alzheimer's Disease and ADRD at Indiana University
-
批准号:10161389
-
项目类别:
-
资助金额:$50.56万
-
财政年份:2021
-
负责人:GARY E. LANDRETH
-
依托单位:
Training Grant on Alzheimer's Disease and ADRD at Indiana University
-
批准号:10393637
-
项目类别:
-
资助金额:$49.45万
-
财政年份:2021
-
负责人:GARY E. LANDRETH
-
依托单位:
Microglial hexokinase 2 as a therapeutic target in Alzheimer's disease
-
批准号:10033043
-
项目类别:
-
资助金额:$204.37万
-
财政年份:2020
-
负责人:GARY E. LANDRETH
-
依托单位:
Academic Leadership Award at the Indiana University School of Medicine
-
批准号:10359680
-
项目类别:
-
资助金额:$16.19万
-
财政年份:2020
-
负责人:GARY E. LANDRETH
-
依托单位:
Academic Leadership Award at the Indiana University School of Medicine
-
批准号:9892249
-
项目类别:
-
资助金额:$16.19万
-
财政年份:2020
-
负责人:GARY E. LANDRETH
-
依托单位:
Academic Leadership Award at the Indiana University School of Medicine
-
批准号:10077811
-
项目类别:
-
资助金额:$16.19万
-
财政年份:2020
-
负责人:GARY E. LANDRETH
-
依托单位:
Actions of Nuclear Receptors on TREM2+ myeloid cells and microglia in AD brain
-
批准号:9104448
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2016
-
负责人:GARY E. LANDRETH
-
依托单位:
Actions of Nuclear Receptors on TREM2+ myeloid cells and microglia in AD brain
-
批准号:9416662
-
项目类别:
-
资助金额:$164.95万
-
财政年份:2016
-
负责人:GARY E. LANDRETH
-
依托单位:
Central and Peripheral Roles of TREM2 in Alzheimer's Disease
-
批准号:9001560
-
项目类别:
-
资助金额:$3.74万
-
财政年份:2015
-
负责人:GARY E. LANDRETH
-
依托单位:
Functional significance of amyloid dynamics and deposition in the AD brain
-
批准号:8576603
-
项目类别:
-
资助金额:$32.49万
-
财政年份:2013
-
负责人:GARY E. LANDRETH
-
依托单位:
Functional significance of amyloid dynamics and deposition in the AD brain
-
批准号:8706756
-
项目类别:
-
资助金额:$32.49万
-
财政年份:2013
-
负责人:GARY E. LANDRETH
-
依托单位:
Functional significance of amyloid dynamics and deposition in the AD brain
-
批准号:8897937
-
项目类别:
-
资助金额:$31.52万
-
财政年份:2013
-
负责人:GARY E. LANDRETH
-
依托单位:
Functional significance of amyloid dynamics and deposition in the AD brain
-
批准号:9084482
-
项目类别:
-
资助金额:$11.38万
-
财政年份:2013
-
负责人:GARY E. LANDRETH
-
依托单位:
Liver X Receptors as Therapeutic Targets in Alzheimer?s Disease
-
批准号:7240705
-
项目类别:
-
资助金额:$2.05万
-
财政年份:2007
-
负责人:GARY E. LANDRETH
-
依托单位:
LXR and PPARgamma mediated Abeta clearance mechanisms
-
批准号:8135055
-
项目类别:
-
资助金额:$29.54万
-
财政年份:2007
-
负责人:GARY E. LANDRETH
-
依托单位:
LXR and PPARgamma mediated Abeta clearance mechanisms
-
批准号:7493420
-
项目类别:
-
资助金额:$31.04万
-
财政年份:2007
-
负责人:GARY E. LANDRETH
-
依托单位:
LXR and PPARgamma mediated Abeta clearance mechanisms
-
批准号:7920201
-
项目类别:
-
资助金额:$46.27万
-
财政年份:2007
-
负责人:GARY E. LANDRETH
-
依托单位:
LXR and PPARgamma mediated Abeta clearance mechanisms
-
批准号:7300936
-
项目类别:
-
资助金额:$31.67万
-
财政年份:2007
-
负责人:GARY E. LANDRETH
-
依托单位: